-
Pfizer's $11.6 Billion Double-acting Migraine Drug Generates $318 Million in First-half Revenue
According to Biohaven's financial report, the double-acting migraine drug rimegepant (trade name: Nurtec) has sales revenue of US$318 million in the f...
2022-08-09 13:48 -
2022H1: Top 10 Best-Selling Drugs in the World
With the release of the semi-annual reports of major pharmaceuticalcompanies in 2022, the TOP10 list of the world's best-selling drugs has becomeclear...
2022-08-05 15:33 -
Vitamin Market Analysis
Recently, market inquiries have been weak, and the market has a strong wait-and-see mood. Mainstream factories frequently release news of production s...
2022-08-02 17:46 -
Market Analysis of Veterinary Drug Raw Materials
Penicillin Potassium Industrial Salt - The market capacity and supply are relatively concentrated. Mainstream factories have raised their quotations, ...
2022-08-02 17:43 -
Huadong Medicine Liraglutide Injection for Obesity or Overweight Indication Application for Listing
On July 12, 2022, Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. (hereinafter referred to as "Zhongmei Huadong"), a wholly-owned subsidiary of Hua...
2022-08-02 13:52 -
Upadatinib's launch accelerated: Crohn's disease has simultaneously submitted marketing applications...
On July 27, AbbVie announced that it had submitted to the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for upadacit...
2022-07-29 18:01 -
Progesterone Market Potential is Huge
Progesterone, a steroid hormone synthesized by the placenta, ovaries and adrenal glands, is essential for reproductive function and regulation of the ...
2022-07-25 14:01 -
Analysis of the Domestic Veterinary Drug Raw Material Market in the 28th Week of 2022
Sulfonamide products are affected by the breeding market, and the overall price has fallen
2022-07-14 17:46 -
Market Analysis of Cephalosporins and Penicillins
Ceftiofur sodium, ceftiofur hydrochloride, cephalosporins fell as a whole, the average market transaction price, ceftiofur sodium 1860, down 18.1% yea...
2022-07-14 17:43 -
AbbVie Ends An Alzheimer's Immunotherapy Collaboration with Alector
AbbVie has decided to terminate a collaboration focused on the development of Alzheimer's disease treatment AL003, Alector disclosed in a filing with ...
2022-07-11 18:00
Hot News
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- Guangdong Jieyang Puts into Op... Jul 16, 2025
- BASF Launches Second Round of ... Jul 24, 2025
Related Products
Related Producers
